Pan-cancer expression analysis revealed that ARID5A was significantly overexpressed in tumor tissues of GBM, KIRC, LAML, and PAAD, while it showed lower expression in tumor tissues of BLCA, BRCA, and CESC (Fig. 11A). The gene discussed is ARID5A; the disease is pancreatic adenocarcinoma.